Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mathias Berger

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Procedures

Chemicals & Drugs

Geographic Areas

Germany

Concepts & Ideas

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
88
Riemann, Dieter
44
Hohagen, Fritz
41
Mühlhauser, Ingrid
32
Voderholzer, Ulrich
27
Sawicki, Peter
27
Härter, Martin
23
Heinemann, Lutz
22
van Calker, Dietrich
19
Bender, R
18
Gaebel, Wolfgang
18
Lieb, Klaus
17
Walden, Jörg
16
Schneider, Frank
16
Jörgens, V
13
Bermejo, Isaac

Sign-in to see all Coauthors

Publications

TOP 3
Walter Henrik; Berger Mathias; Schnell Knut
Neuropsychotherapy: conceptual, empirical and neuroethical issues.
Bermejo Isaac; Berger Mathias; Kriston Levente; Härter Martin
[Is patient's satisfaction with inpatient depression treatment related to their German language proficiency?]
Riemann D; Kloepfer C; Berger M
Functional and structural brain alterations in insomnia: implications for pathophysiology.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mathias Berger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Walter Henrik; Berger Mathias; Schnell Knut
Neuropsychotherapy: conceptual, empirical and neuroethical issues.
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S173-82.
2009: Bermejo Isaac; Berger Mathias; Kriston Levente; Härter Martin
[Is patient's satisfaction with inpatient depression treatment related to their German language proficiency?]
Psychiatrische Praxis 2009;36(6):279-85.
2009: Riemann D; Kloepfer C; Berger M
Functional and structural brain alterations in insomnia: implications for pathophysiology.
The European journal of neuroscience 2009;29(9):1754-60.
2009: Berger M; Brakemeier E L; Klesse C; Schramm E
[Affective disorders. The significance of psychotherapeutic approaches]
Der Nervenarzt 2009;80(5):540, 542-4, 546-8 passim.
2009: Schredl Michael; Berger Mathias; Riemann Dieter
The effect of trimipramine on dream recall and dream emotions in depressive outpatients.
Psychiatry research 2009;167(3):279-86.
2009: van Calker Dietrich; Zobel Ingo; Dykierek Petra; Deimel Christoph Michael; Kech Sabine; Lieb Klaus; Berger Mathias; Schramm Elisabeth
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.
Journal of affective disorders 2009;114(1-3):243-53.
2009: Bermejo Isaac; Schneider Frank; Kriston Levente; Gaebel Wolfgang; Hegerl Ulrich; Berger Mathias; Härter Martin
Improving outpatient care of depression by implementing practice guidelines: a controlled clinical trial.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2009;21(1):29-36.
2008: Wündrich M; Peters J; Philipsen A; Kopasz M; Berger M; Voderholzer U
[Clinical teaching with simulated patients in psychiatry and psychotherapy. A controlled pilot study]
Der Nervenarzt 2008;79(11):1273-4, 1276, 1278, passim.
2008: Schierenbeck Thomas; Riemann Dieter; Berger Mathias; Hornyak Magdolna
Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana.
Sleep medicine reviews 2008;12(5):381-9.
2008: Schramm Elisabeth; Schneider Daniel; Zobel Ingo; van Calker Dietrich; Dykierek Petra; Kech Sabine; Härter Martin; Berger Mathias
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
Journal of affective disorders 2008;109(1-2):65-73.
2008: Brakemeier E-L; Normann C; Berger M
[The etiopathogenesis of unipolar depression. Neurobiological and psychosocial factors]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008;51(4):379-91.
2008: Härter Martin; Klesse C; Bermejo I; Lelgemann M; Weinbrenner S; Ollenschläger G; Kopp I; Berger M
[Development of national guidelines for depression]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008;51(4):451-7.
2008: Schneider Daniel; Zobel Ingo; Härter Martin; Kech Sabine; Berger Mathias; Schramm Elisabeth
[Is interpersonal psychotherapy a woman specific method? Results of a randomized controlled study]
Psychotherapie, Psychosomatik, medizinische Psychologie 2008;58(1):23-31.
2007: Stamm K; Salize H J; Härter M; Brand S; Sitta P; Berger M; Gaebel W; Schneider F
[Cost predictors of depressive inpatient episodes in Germany. The health insurer's point of view]
Der Nervenarzt 2007;78(6):665-71.
2007: Schramm Elisabeth; van Calker Dietrich; Dykierek Petra; Lieb Klaus; Kech Sabine; Zobel Ingo; Leonhart Rainer; Berger Mathias
An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results.
The American journal of psychiatry 2007;164(5):768-77.
2007: Voderholzer Ulrich; Riemann Dieter; Huwig-Poppe Christine; Kuelz Anne Katrin; Kordon Andreas; Bruestle Katharina; Berger Mathias; Hohagen Fritz
Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency.
European archives of psychiatry and clinical neuroscience 2007;257(3):173-82.
2006: Nissen Christoph; Power Ann E; Nofzinger Eric A; Feige Bernd; Voderholzer Ulrich; Kloepfer Corinna; Waldheim Bernhard; Radosa Marc-Philipp; Berger Mathias; Riemann Dieter
M1 muscarinic acetylcholine receptor agonism alters sleep without affecting memory consolidation.
Journal of cognitive neuroscience 2006;18(11):1799-807.
2006: Nissen Christoph; Nofzinger Eric A; Feige Bernd; Waldheim Bernhard; Radosa Marc-Philipp; Riemann Dieter; Berger Mathias
Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(6):1294-300.
2006: Härter Martin; Bermejo Isaac; Ollenschläger Günter; Schneider Frank; Gaebel Wolfgang; Hegerl Ulrich; Niebling Wilhelm; Berger Mathias
Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2006;18(2):113-9.
2006: Sitta Petra; Brand Silke; Schneider Frank; Gaebel Wolfgang; Berger Mathias; Farin Erik; Härter Martin
[Duration of inpatient depression treatment--fair benchmarking between hospitals]
Psychotherapie, Psychosomatik, medizinische Psychologie 2006;56(3-4):128-37.
2006: Schramm E; Caspar F; Berger M
[A specific therapy for chronic depression. McCullough's Cognitive Behavioral Analysis System of Psychotherapy]
Der Nervenarzt 2006;77(3):355-70; quiz 371.
2006: Hüll Michael; Berger Mathias; Heneka Michael
Disease-modifying therapies in Alzheimer's disease: how far have we come?
Drugs 2006;66(16):2075-93.
2005: Schneider Frank; Härter Martin; Brand Silke; Sitta Petra; Menke Ralph; Hammer-Filipiak Ursula; Kudling Ralf; Heindl Andrea; Herold Kurt; Frommberger Ulrich; Elmer Olivier; Hetzel Günter; Witt Gabriele; Wolfersdorf Manfred; Berger Mathias; Gaebel Wolfgang
Adherence to guidelines for treatment of depression in in-patients.
The British journal of psychiatry : the journal of mental science 2005;187():462-9.
2005: Hornyak Magdolna; Kopasz Marta; Berger Mathias; Riemann Dieter; Voderholzer Ulrich
Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.
The Journal of clinical psychiatry 2005;66(9):1139-45.
2005: Brand S; Härter M; Sitta P; van Calker D; Menke R; Heindl A; Herold K; Kudling R; Luckhaus C; Rupprecht U; Sanner Dirk; Schmitz D; Schramm E; Berger M; Gaebel W; Schneider F
[Data supporting quality circle management of inpatient depression treatment]
Der Nervenarzt 2005;76(7):865-6, 868-72, 873-4.
2005: Nissen Christoph; Feige Bernd; Nofzinger Eric; Riemann Dieter; Berger Mathias; Voderholzer Ulrich
Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine.
Journal of sleep research 2005;14(2):207-8.
2005: Janssen B; Weinmann S; Berger M; Härter M; Held T; Leipert M; Luderer H J; Schwarz M; Steinert T; Gaebel W
[Guideline conformity and outcome of inpatient treatment for schizophrenia. A clinical comparison]
Der Nervenarzt 2005;76(3):315-26.
2005: Schneider F; Menke R; Härter M; Salize H J; Janssen B; Bergmann F; Berger M; Gaebel W
[Are bonus systems applicable to guideline-oriented depression treatment provided by general practitioners and neurologists?]
Der Nervenarzt 2005;76(3):308-14.
2005: Wehmeier P M; Kluge M; Maras A; Riemann D; Berger M; Kohnen R; Dittmann R W; Gattaz W F
Fluoxetine versus trimipramine in the treatment of depression in geriatric patients.
Pharmacopsychiatry 2005;38(1):13-6.
2004: Härter M; Sitta P; Keller F; Metzger R; Wiegand W; Schell G; Stieglitz R-D; Wolfersdorf M; Felsenstein M; Berger M
[Psychiatric-psychotherapeutic inpatient treatment for depression. Process and outcome quality based on a model project in Baden-Wurttemberg]
Der Nervenarzt 2004;75(11):1083-91.
2004: Gann Horst; van Calker Dietrich; Feige Bernd; Cloot Oliver; Brück Rigo; Berger Mathias; Riemann Dieter
Polysomnographic comparison between patients with primary alcohol dependency during subacute withdrawal and patients with a major depression.
European archives of psychiatry and clinical neuroscience 2004;254(4):263-71.
2004: Voderholzer Ulrich; Hohagen Fritz; Klein Torsten; Jungnickel Julia; Kirschbaum Clemens; Berger Mathias; Riemann Dieter
Impact of sleep deprivation and subsequent recovery sleep on cortisol in unmedicated depressed patients.
The American journal of psychiatry 2004;161(8):1404-10.
2004: Barkow Katrin; Heun Reinhard; Ustün T Bedirhan; Berger Mathias; Bermejo Isaac; Gaebel Wolfgang; Härter Martin; Schneider Frank; Stieglitz Rolf-Dieter; Maier Wolfgang
Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care.
European psychiatry : the journal of the Association of European Psychiatrists 2004;19(5):250-7.
2004: Salize Hans Joachim; Stamm Klaus; Schubert Matthias; Bergmann Frank; Härter Martin; Berger Mathias; Gaebel Wolfgang; Schneider Frank
[Cost of care for depressive disorders in primary and specialized care in Germany]
Psychiatrische Praxis 2004;31(3):147-56.
2004: Schramm Elisabeth; van Calker Dietrich; Berger Mathias
[Efficacy and therapeutic factors of interpersonal psychotherapy for depressed inpatients - results of a pilot study]
Psychotherapie, Psychosomatik, medizinische Psychologie 2004;54(2):65-72.
2004: Schneider Frank; Kratz Sandra; Bermejo Isaac; Menke Ralph; Mulert Christoph; Hegerl Ulrich; Berger Mathias; Gaebel Wolfgang; Härter Martin
Insufficient depression treatment in outpatient settings.
German medical science : GMS e-journal 2004;2():Doc01.
2004: Janssen Birgit; Weinmann Stefan; Berger Mathias; Gaebel Wolfgang
Validation of polypharmacy process measures in inpatient schizophrenia care.
Schizophrenia bulletin 2004;30(4):1023-33.
2003: Menke Ralph; Schneider Frank; Härter Martin; Salize Hans Joachim; Berger Mathias; Gaebel Wolfgang
[Cost optimization of the outpatient management of depression]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():74-9.
2003: Schneider Frank; Härter Martin; Kratz Sandra; Bermejo Isaac; Mulert Christoph; Hegerl Ulrich; Gaebel Wolfgang; Berger Mathias
[Subjectively-perceived inappropriate treatment of depressed patients in general and psychiatric practice]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():57-66.
2003: Kratz Sandra; Härter Martin; Bermejo Isaac; Berger Mathias; Schneider Frank; Gaebel Wolfgang
[Reason for encounter and diagnosis of depression in patients in general practice]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():50-6.
2003: Bermejo Isaac; Kratz Sandra; Schneider Frank; Gaebel Wolfgang; Mulert Christoph; Hegerl Ulrich; Berger Mathias; Härter Martin
[Agreement in physicians' and patients' assessment of depressive disorders]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():44-9.
2003: Härter Martin; Bermejo Isaac; Schneider Frank; Kratz Sandra; Gaebel Wolfgang; Hegerl Ulrich; Niebling Wilhelm; Berger Mathias
[Clinical practice guidelines for the diagnosis and therapy of depressive disorders in primary care]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():16-35.
2003: Härter Martin; Bermejo Isaac; Schneider Frank; Gaebel Wolfgang; Niebling Wilhelm; Berger Mathias
[Comprehensive ambulatory care quality management for patients with depressive disorders]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2003;97 Suppl 4():9-15.
2003: Nyberg E; Stieglitz R D; Frommberger U; Berger M
[Psychological disorders after severe occupational accidents]
Versicherungsmedizin / herausgegeben von Verband der Lebensversicherungs-Unternehmen e.V. und Verband der Privaten Krankenversicherung e.V 2003;55(2):76-81.
2003: Riemann D; Hornyak M; Voderholzer U; Berger M
[Algorithms for diagnosis and therapy of sleep disorders in general practice]
MMW Fortschritte der Medizin 2003;145 Suppl 2():55-60.
2003: Riemann D; Voderholzer U; Berger M
[Non-restorative sleep and insomnia. Diagnostic and therapeutic options for psychiatry and psychotherapy]
Der Nervenarzt 2003;74(5):450-67; quiz 468-9.
2003: Voderholzer U; Valerius G; Schaerer L; Riemann D; Giedke H; Schwärzler F; Berger M; Wiegand M
Is the antidepressive effect of sleep deprivation stabilized by a three day phase advance of the sleep period? A pilot study.
European archives of psychiatry and clinical neuroscience 2003;253(2):68-72.
2003: Berger M; van Calker D; Riemann D
Sleep and manipulations of the sleep-wake rhythm in depression.
Acta psychiatrica Scandinavica. Supplementum 2003;(418):83-91.
2002: Lieb Klaus; Ahlvers Katrin; Dancker Katharina; Strohbusch Stefan; Reincke Martin; Feige Bernd; Berger Mathias; Riemann Dieter; Voderholzer Ulrich
Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(6):1041-9.
2002: Voderholzer Ulrich; Riemann Dieter; Gann Horst; Hornyak Magdolna; Juengling Freimut; Schumacher Martin; Reincke Martin; Von Herbay Axel; Nishino Seiji; Mignot Emmanuel; Berger Mathias; Lieb Klaus
Transient total sleep loss in cerebral Whipple's disease: a longitudinal study.
Journal of sleep research 2002;11(4):321-9.
2002: Ebert D; Berger M; Hesslinger B
[ADHD as a risk factor for delinquency and personality disorders? Recognizing the patient at risk]
MMW Fortschritte der Medizin 2002;144(47):31-3.
2002: Lieb K; Herpfer I; Fiebich B L; Berger M
[Substance P-antagonists as a new class of antidepressant drugs]
Deutsche medizinische Wochenschrift (1946) 2002;127(48):2563-5.
2002: Mühlhauser I; Sawicki P T; Blank M; Overmann H; Richter B; Berger M
Reliability of causes of death in persons with Type I diabetes.
Diabetologia 2002;45(11):1490-7.
2002: Bermejo Isaac; Lohmann Antonia; Berger Mathias; Härter Martin
[Barriers and need for support in the primary care of depressive patients]
Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 2002;96(9):605-13.
2002: Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand M H; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
Pharmacopsychiatry 2002;35(5):165-74.
2002: Linkeschova R; Raoul M; Bott U; Berger M; Spraul M
Less severe hypoglycaemia, better metabolic control, and improved quality of life in Type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(9):746-51.
2002: Hesslinger B; Härter M; Barth J; Klecha D; Bode C; Walden J; Bengel J; Berger M
[Comorbidity of depressive disorders and cardiovascular diseases. Implications for diagnosis, pharmaco- and psychotherapy]
Der Nervenarzt 2002;73(3):205-17; quiz 218.
2002: Feige Bernd; Voderholzer Ulrich; Riemann Dieter; Dittmann Ralf; Hohagen Fritz; Berger Mathias
Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):246-58.
2002: Neuvians T P; Berger M
Diabetes care in cats and dogs.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(1):77-9.
2002: Trautner C; Haastert B; Giani G; Berger M
Amputations and diabetes: a case-control study.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(1):35-40.
2002: Voderholzer Ulrich; Weske Gesa; Ecker Sabine; Riemann Dieter; Gann Horst; Berger Mathias
Neurobiological findings before and during successful lithium therapy of a patient with 48-hour rapid-cycling bipolar disorder.
Neuropsychobiology 2002;45 Suppl 1():13-9.
2002: Riemann Dieter; Voderholzer Ulrich; Berger Mathias
Sleep and sleep-wake manipulations in bipolar depression.
Neuropsychobiology 2002;45 Suppl 1():7-12.
2002: Lieb Klaus; Treffurth Yvonne; Berger Mathias; Fiebich Bernd L
Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?
Neuropsychobiology 2002;45 Suppl 1():2-6.
2001: Härter M; Bermejo I; Aschenbrenner A; Berger M
[Analysis and evaluation of current guidelines for diagnosis and treatment of depressive disorders:]
Fortschritte der Neurologie-Psychiatrie 2001;69(9):390-401.
2001: Weske G; Berger M; Riemann D; Voderholzer U
[Neurobiological findings in a patient with 48-hour rapid cycling bipolar affective disorder. A case report]
Der Nervenarzt 2001;72(7):549-54.
2001: Riemann D; Berger M; Voderholzer U
Sleep and depression--results from psychobiological studies: an overview.
Biological psychology 2001;57(1-3):67-103.
2001: Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
European archives of psychiatry and clinical neuroscience 2001;251(3):117-23.
2001: Nissen C; Feige B; König A; Voderholzer U; Berger M; Riemann D
Delta sleep ratio as a predictor of sleep deprivation response in major depression.
Journal of psychiatric research 2001;35(3):155-63.
2001: Weske G; Voderholzer U; Riemann D; Berger M
[Sleep disorders. Differential diagnosis and therapy in general practice]
MMW Fortschritte der Medizin 2001;143 Suppl 2():5-8, 10, 12.
2001: Trautner C; Haastert B; Spraul M; Giani G; Berger M
Unchanged incidence of lower-limb amputations in a German City, 1990-1998.
Diabetes care 2001;24(5):855-9.
2001: Stieglitz R D; Frommberger U; Foa E B; Berger M
Evaluation of the German version of the PTSD Symptom Scale (PSS).
Psychopathology 2001;34(3):128-33.
2001: Wolf R; Dykierek P; Gattaz W F; Maras A; Kohnen R; Dittmann R W; Geuppert M; Riemann D; Berger M
Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Pharmacopsychiatry 2001;34(2):60-5.
2001: Trautner C; Haastert B; Giani G; Berger M
Incidence of blindness in southern Germany between 1990 and 1998.
Diabetologia 2001;44(2):147-50.
2001: Schumann G; Benedetti F; Voderholzer U; Kammerer N; Hemmeter U; Travers H W; Fiebich B; Holsboer-Trachsler E; Berger M; Seifritz E; Ebert D
Antidepressive response to sleep deprivation in unipolar depression is not associated with dopamine D3 receptor genotype.
Neuropsychobiology 2001;43(3):127-30.
2000: Mühlhauser I; Overmann H; Bender R; Jörgens V; Berger M
Predictors of mortality and end-stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(10):727-34.
2000: Mühlhauser I; Sawicki P T; Blank M; Overmann H; Bender R; Berger M
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy.
Journal of internal medicine 2000;248(4):333-41.
2000: Bott U; Bott S; Hemmann D; Berger M
Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(9):635-43.
2000: Müller U A; Femerling M; Risse A; Schumann M; Use G; Jörgens V; Berger M
[Self-treatment instruction of patients with type 1 diabetes. Report from hospitals belonging to Working Group for Structured Diabetes Therapy (ASD) in Germany 1998]
Medizinische Klinik (Munich, Germany : 1983) 2000;95(7):359-68.
2000: Richter B; Bender R; Berger M
Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.
Journal of internal medicine 2000;247(6):657-66.
2000: Richter B; Berger M
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate)
Diabetologia 2000;43(4):528-32.
2000: Schredl M; Weber B; Braus D; Gattaz W F; Berger M; Riemann D; Heuser I
The effect of rivastigmine on sleep in elderly healthy subjects.
Experimental gerontology 2000;35(2):243-9.
2000: Berner M M; Rüther A; Stieglitz R D; Berger M
[The concept of "evidence-based medicine" in psychiatry. A path to a more rational psychiatry?]
Der Nervenarzt 2000;71(3):173-80.
2000: Richter B; Berger M
Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate) [corrected]
Diabetologia 2000;43(2):254-8.
2000: Sawicki P T; Bender R; Berger M; Mühlhauser I
Non-linear effects of blood pressure and glycosylated haemoglobin on progression of diabetic nephropathy.
Journal of internal medicine 2000;247(1):131-8.
1999: Lieb K; Maiwald M; Berger M; Voderholzer U
Insomnia for 5 years.
Lancet 1999;354(9194):1966.
1999: Feige B; Voderholzer U; Riemann D; Hohagen F; Berger M
Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 1999;110(11):1965-74.
1999: Hesslinger B; Normann C; Langosch J M; Klose P; Berger M; Walden J
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Journal of clinical psychopharmacology 1999;19(4):310-5.
1999: Berger M; Mühlhauser I
Diabetes care and patient-oriented outcomes.
JAMA : the journal of the American Medical Association 1999;281(18):1676-8.
1999: Frommberger U; Stieglitz R D; Straub S; Nyberg E; Schlickewei W; Kuner E; Berger M
The concept of "sense of coherence" and the development of posttraumatic stress disorder in traffic accident victims.
Journal of psychosomatic research 1999;46(4):343-8.
1999: Bender R; Jöckel K H; Trautner C; Spraul M; Berger M
Effect of age on excess mortality in obesity.
JAMA : the journal of the American Medical Association 1999;281(16):1498-504.
1999: Berger M; Jörgens V; Mühlhauser I
Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes.
Diabetes care 1999;22 Suppl 3():C71-5.
1999: Müller U A; Femerling M; Reinauer K M; Risse A; Voss M; Jörgens V; Berger M; Mühlhauser I
Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).
Diabetes care 1999;22 Suppl 2():B29-34.
1999: Riemann D; König A; Hohagen F; Kiemen A; Voderholzer U; Backhaus J; Bunz J; Wesiack B; Hermle L; Berger M
How to preserve the antidepressive effect of sleep deprivation: A comparison of sleep phase advance and sleep phase delay.
European archives of psychiatry and clinical neuroscience 1999;249(5):231-7.
1999: Spraul M; Schönbach A M; Mühlhauser I; Berger M
[Amputations and mortality in elderly insulin-treated patients with type 2 diabetes]
Zentralblatt für Chirurgie 1999;124(6):501-7.
1998: Ebert D; Berger M
Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation.
Psychopharmacology 1998;140(1):1-10.
1998: Braun J S; Apel I; Schäffer S; Schumacher M; Berger M
[Delirium during oral therapy of herpes zoster with acyclovir. Case report and brief review of central nervous system side-effects of acyclovir]
Der Nervenarzt 1998;69(11):1015-8.
1998: Normann C; Hesslinger B; Bauer J; Berger M; Walden J
[Significance of hepatic cytochrome P450 enzymes for psychopharmacology]
Der Nervenarzt 1998;69(11):944-55.
1998: Spleiss O; van Calker D; Schärer L; Adamovic K; Berger M; Gebicke-Haerter P J
Abnormal G protein alpha(s) - and alpha(i2)-subunit mRNA expression in bipolar affective disorder.
Molecular psychiatry 1998;3(6):512-20.
1998: Mühlhauser I; Overmann H; Bender R; Bott U; Berger M
Risk factors of severe hypoglycaemia in adult patients with Type I diabetes--a prospective population based study.
Diabetologia 1998;41(11):1274-82.
1998: Hecht H; van Calker D; Berger M; von Zerssen D
Personality in patients with affective disorders and their relatives.
Journal of affective disorders 1998;51(1):33-43.
1998: Mühlhauser I; Overmann H; Bender R; Bott U; Jörgens V; Trautner C; Siegrist J; Berger M
Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus--a population-based study.
Diabetologia 1998;41(10):1139-50.
1998: Normann C; Brandt C; Berger M; Walden J
Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
Pharmacopsychiatry 1998;31(5):201-4.
1998: Gebicke-Haerter P J; Lieb K; Illes P; Berger M
[Microglia: mechanisms of activation and significance in pathogenesis of neuropsychiatric illnesses]
Der Nervenarzt 1998;69(9):752-62.
1998: Langosch J M; Repp M; Berger M; Walden J
Effects of the atypical antidepressant trimipramine on field potentials in the low Mg2+-model in guinea pig hippocampal slices.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(3):209-12.
1998: Hornyak M; Voderholzer U; Hohagen F; Berger M; Riemann D
Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study.
Sleep 1998;21(5):501-5.
1998: Langosch J M; Normann C; Schirrmacher K; Berger M; Walden J
The influence of (+/-)-kavain on population spikes and long-term potentiation in guinea pig hippocampal slices.
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 1998;120(3):545-9.
1998: Braun J S; Geiger R; Wehner H; Schäffer S; Berger M
Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
Pharmacopsychiatry 1998;31(4):152-5.
1998: Spleiss O; Gourmala N; Boddeke H W; Sauter A; Fiebich B L; Berger M; Gebicke-Haerter P J
Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of its mRNA in ischemic and endotoxinemic rat brain.
Journal of neuroscience research 1998;53(1):16-28.
1998: Voderholzer U; Backhaus J; Hornyak M; Hohagen F; Berger M; Riemann D
A 19-h spontaneous sleep period in idiopathic central nervous system hypersomnia.
Journal of sleep research 1998;7(2):101-3.
1998: Bohus M; Schehr K; Berger-Sallawitz F; Novelli-Fischer U; Stieglitz R D; Berger M
[Children of mentally ill parents. A study of problem awareness in clinical routine practice]
Psychiatrische Praxis 1998;25(3):134-8.
1998: Bott U; Mühlhauser I; Overmann H; Berger M
Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes.
Diabetes care 1998;21(5):757-69.
1998: Hesslinger B; Klose P; Normann C; Langosch J M; Berger M; Walden J
[Adjuvant treatment of schizophrenic illness with carbamazepine]
Fortschritte der Neurologie-Psychiatrie 1998;66(4):145-50.
1998: Sawicki P T; Berger M
Pharmacological treatment of diabetic patients with cardiovascular complications.
Journal of internal medicine 1998;243(3):181-9.
1998: Voderholzer U; Hornyak M; Thiel B; Huwig-Poppe C; Kiemen A; König A; Backhaus J; Riemann D; Berger M; Hohagen F
Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;18(2):112-24.
1998: Dykierek P; Stadtmüller G; Schramm P; Bahro M; van Calker D; Braus D F; Steigleider P; Löw H; Hohagen F; Gattaz W F; Berger M; Riemann D
The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging.
Journal of psychiatric research 1998;32(1):1-9.
1998: Stieglitz R D; Wolfersdorf M; Metzger R; Ruppe A; Stabenow S; Hornstein C; Keller F; Schell G; Berger M
[Inpatient treatment of depressed patents. Conceptual considerations and results of a pilot project for quality assurance in Baden-Württemberg]
Der Nervenarzt 1998;69(1):59-65.
1998: Sawicki P T; Kiwitt S; Bender R; Berger M
The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus.
Journal of internal medicine 1998;243(1):49-56.
1998: Bender R; Trautner C; Spraul M; Berger M
Assessment of excess mortality in obesity.
American journal of epidemiology 1998;147(1):42-8.
1998: Gann H J; Faulmann A; Kiemen A; Klein T; Ebert D; Backhaus J; Hornyak M; Voderholzer U; Hohagen F; Berger M; Riemann D
Sleep and the cholinergic rem sleep induction test in patients with primary alcoholism.
Sleep research online : SRO 1998;1(2):92-5.
1998: Frommberger U H; Stieglitz R D; Nyberg E; Schlickewei W; Kuner E; Berger M
Prediction of posttraumatic stress disorder by immediate reactions to trauma: a prospective study in road traffic accident victims.
European archives of psychiatry and clinical neuroscience 1998;248(6):316-21.
1998: Berger M
[Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy]
Zeitschrift für Kardiologie 1998;87 Suppl 2():210-3.
1998: Bott U; Berger M
[Is it possible to predict the success of an intensified program of insulin therapy?]
Journées annuelles de diabétologie de l'Hôtel-Dieu 1998;():289-313.
1998: Hüll M; Fiebich B L; Dykierek P; Schmidtke K; Nitzsche E; Orszagh M; Deuschl G; Moser E; Schumacher M; Lücking C; Berger M; Bauer J
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139.
European archives of psychiatry and clinical neuroscience 1998;248(3):123-9.
1998: Spleiss O; Appel K; Boddeke H W; Berger M; Gebicke-Haerter P J
Molecular biology of microglia cytokine and chemokine receptors and microglial activation.
Life sciences 1998;62(17-18):1707-10.
1997: Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
Pharmacopsychiatry 1997;30(6):263-5.
1997: Lieb K; Fiebich B L; Berger M; Bauer J; Schulze-Osthoff K
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):4952-8.
1997: Lieb K; Vaith P; Berger M; Bauer J
[Systemic immunologic diseases as differential diagnosis in psychiatry]
Der Nervenarzt 1997;68(9):696-707.
1997: Lubrich B; Patishi Y; Kofman O; Agam G; Berger M; Belmaker R H; van Calker D
Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus.
Molecular psychiatry 1997;2(5):407-12.
1997: Bott S; Bott U; Berger M; Mühlhauser I
Intensified insulin therapy and the risk of severe hypoglycaemia.
Diabetologia 1997;40(8):926-32.
1997: Sawicki P T; Heise T; Berger M
Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
Diabetologia 1997;40 Suppl 2():S134-7.
1997: Berger M; Heinemann L
Are presently available insulin analogues clinically beneficial?
Diabetologia 1997;40 Suppl 2():S91-6.
1997: Icks A; Trautner C; Haastert B; Berger M; Giani G
Blindness due to diabetes: population-based age- and sex-specific incidence rates.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(7):571-5.
1997: Trautner C; Icks A; Haastert B; Plum F; Berger M
Incidence of blindness in relation to diabetes. A population-based study.
Diabetes care 1997;20(7):1147-53.
1997: Berger M; Vollmann J; Hohagen F; König A; Lohner H; Voderholzer U; Riemann D
Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients.
The American journal of psychiatry 1997;154(6):870-2.
1997: Wolfersdorf M; Stieglitz R D; Metzger R; Ruppe A; Stabenow S; Hornstein C; Keller F; Schell G; Berger M
[Quality assurance in inpatient treatment of depression. Aspects of quality monitoring and external quality assurance exemplified by a pilot project of inpatient treatment of depression]
Psychiatrische Praxis 1997;24(3):120-8.
1997: Walden J; von Wegerer J; Winter U; Berger M; Grunze H
Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.
Progress in neuro-psychopharmacology & biological psychiatry 1997;21(4):697-706.
1997: von Wegerer J; Hesslinger B; Berger M; Walden J
A calcium antagonistic effect of the new antiepileptic drug lamotrigine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):77-81.
1997: Baving L; Maes H; Bohus M; Lis S; Krieger S; Olbrich H; Berger M
Can negative self-schemes in depressives be altered through sleep deprivation?
Journal of affective disorders 1997;42(2-3):93-101.
1997: Frommberger U H; Bauer J; Haselbauer P; Fräulin A; Riemann D; Berger M
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
European archives of psychiatry and clinical neuroscience 1997;247(4):228-33.
1997: Hecht H; van Calker D; Spraul G; Bohus M; Wark H J; Berger M; von Zerssen D
Premorbid personality in patients with uni- and bipolar affective disorders and controls: assessment by the Biographical Personality Interview (BPI).
European archives of psychiatry and clinical neuroscience 1997;247(1):23-30.
1996: Bohus M; Förstner U; Kiefer C; Gebicke-Härter P; Timmer J; Spraul G; Wark H J; Hecht H; Berger M; van Calker D
Increased sensitivity of the inositol-phospholipid system in neutrophils from patients with acute major depressive episodes.
Psychiatry research 1996;65(1):45-51.
1996: Lieb K; Fiebich B L; Schaller H; Berger M; Bauer J
Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B.
Journal of neurochemistry 1996;67(5):2039-44.
1996: Rösler N; Hüll M; Lieb K; Wolf R; Berger M; Bauer J
[Dementias--diagnosis, differential diagnosis and therapy]
Fortschritte der Medizin 1996;114(28):351-6.
1996: Trautner C; Icks A; Haastert B; Plum F; Berger M; Giani G
Diabetes as a predictor of mortality in a cohort of blind subjects.
International journal of epidemiology 1996;25(5):1038-43.
1996: Fiebich B L; Biber K; Lieb K; van Calker D; Berger M; Bauer J; Gebicke-Haerter P J
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors.
Glia 1996;18(2):152-60.
1996: Weyerbrock A; Timmer J; Hohagen F; Berger M; Bauer J
Effects of light and chronotherapy on human circadian rhythms in delayed sleep phase syndrome: cytokines, cortisol, growth hormone, and the sleep-wake cycle.
Biological psychiatry 1996;40(8):794-7.
1996: Biber K; Walden J; Gebicke-Härter P; Berger M; van Calker D
Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphosphate formation in hippocampal astrocyte cultures.
Biological psychiatry 1996;40(7):563-7.
1996: Lieb K; Dammann G; Berger M; Bauer J
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]
Der Nervenarzt 1996;67(9):711-20.
1996: Walden J; Hesslinger B; van Calker D; Berger M
Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder.
Pharmacopsychiatry 1996;29(5):193-5.
1996: Trautner C; Haastert B; Giani G; Berger M
Incidence of lower limb amputations and diabetes.
Diabetes care 1996;19(9):1006-9.
1996: Vauth R; Hohagen F; von Calker D; Berger M
[Organization of practice oriented knowledge structures by the "cognitive apprenticeship" method]
Zeitschrift für ärztliche Fortbildung 1996;90(5):459-64.
1996: Härter M; Vauth R; Tausch B; Berger M
[Goals, content and evaluation of training seminars for quality circle moderators]
Zeitschrift für ärztliche Fortbildung 1996;90(5):394-9.
1996: Heinemann L; Heise T; Wahl L C; Trautmann M E; Ampudia J; Starke A A; Berger M
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(7):625-9.
1996: Berger M
To bridge science and patient care in diabetes.
Diabetologia 1996;39(7):749-57.
1996: Gebicke-Haerter P J; Christoffel F; Timmer J; Northoff H; Berger M; Van Calker D
Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation.
Neurochemistry international 1996;29(1):37-42.
1996: Lieb K; Fiebich B L; Busse-Grawitz M; Hüll M; Berger M; Bauer J
Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 beta and interleukin-6 in human monocytes: a re-examination.
Journal of neuroimmunology 1996;67(2):77-81.
1996: Mühlhauser I; Bender R; Bott U; Jörgens V; Grüsser M; Wagener W; Overmann H; Berger M
Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1996;13(6):536-43.
1996: Hüll M; Strauss S; Berger M; Volk B; Bauer J
The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease.
Behavioural brain research 1996;78(1):37-41.
1996: Voderholzer U; Riemann D; Hohagen F; König A; Berger M
[Sleep and depression]
Der Internist 1996;37(5):483-9.
1996: Hesslinger B; Riedel H; Hellwig B; Walden J; Berger M
[Phase prevention in bipolar affective disorder with nimodipine. A case report]
Der Nervenarzt 1996;67(5):394-6.
1996: Riemann D; Lis S; Fritsch-Montero R; Meier T; Krieger S; Hohagen F; Berger M
Effect of tetrahydroaminoacridine on sleep in healthy subjects.
Biological psychiatry 1996;39(9):796-802.
1996: Fiebich B L; Lieb K; Hüll M; Berger M; Bauer J
Effects of NSAIDs on IL-1 beta-induced IL-6 mRNA and protein synthesis in human astrocytoma cells.
Neuroreport 1996;7(6):1209-13.
1996: Sawicki P T; Mühlhauser I; Bender R; Pethke W; Heinemann L; Berger M
Effects of smoking on blood pressure and proteinuria in patients with diabetic nephropathy.
Journal of internal medicine 1996;239(4):345-52.
1996: Riemann D; Hohagen F; König A; Schwarz B; Gomille J; Voderholzer U; Berger M
Advanced vs. normal sleep timing: effects on depressed mood after response to sleep deprivation in patients with a major depressive disorder.
Journal of affective disorders 1996;37(2-3):121-8.
1996: Lieb K; Kaltschmidt C; Kaltschmidt B; Baeuerle P A; Berger M; Bauer J; Fiebich B L
Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373.
Journal of neurochemistry 1996;66(4):1496-503.
1996: Fiebich B L; Biber K; Gyufko K; Berger M; Bauer J; van Calker D
Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells.
Journal of neurochemistry 1996;66(4):1426-31.
1996: Patishi Y; Lubrich B; Berger M; Kofman O; van Calker D; Belmaker R H
Differential uptake of myo-inositol in vivo into rat brain areas.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1996;6(1):73-5.
1996: Hesslinger B; Hellwig B; Sester U; Walden J; Berger M
An acute psychotic disorder caused by pefloxacin: a case report.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(2):343-7.
1996: Mülhauser I; Prange K; Sawicki P T; Bender R; Dworschak A; Schaden W; Berger M
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Diabetologia 1996;39(2):212-9.
1996: Sawicki P T; Dähne R; Bender R; Berger M
Prolonged QT interval as a predictor of mortality in diabetic nephropathy.
Diabetologia 1996;39(1):77-81.
1996: Hüll M; Berger M; Volk B; Bauer J
Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques.
Annals of the New York Academy of Sciences 1996;777():205-12.
1996: Berger M; Gastpar M
Trimipramine: a challenge to current concepts on antidepressives.
European archives of psychiatry and clinical neuroscience 1996;246(5):235-9.
1996: Hüll M; Strauss S; Berger M; Volk B; Bauer J
Inflammatory mechanisms in Alzheimer's disease.
European archives of psychiatry and clinical neuroscience 1996;246(3):124-8.
1995: Fiebich B L; Lieb K; Berger M; Bauer J
Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells.
Journal of neuroimmunology 1995;63(2):207-11.
1995: Kimmerle R; Heinemann L; Berger M
Intrauterine devices are safe and effective contraceptives for type I diabetic women.
Diabetes care 1995;18(11):1506-7.
1995: Sawicki P T; Mühlhauser I; Didjurgeit U; Reimann M; Bender R; Berger M
Mortality and morbidity in treated hypertensive type 2 diabetic patients with micro- or macroproteinuria.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(10):893-8.
1995: Sawicki P T; Mühlhauser I; Didjurgeit U; Berger M
Effects of intensification of antihypertensive care in diabetic nephropathy.
Journal of diabetes and its complications 1995;9(4):315-7.
1995: Gann H; Riemann D; Stoll S; Berger M; Müller W E
Growth hormone response to growth hormone-releasing hormone and clonidine in depression.
Biological psychiatry 1995;38(5):325-9.
1995: Sawicki P T; Mühlhauser I; Didjurgeit U; Baumgartner A; Bender R; Berger M
Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy.
Journal of hypertension 1995;13(8):933-8.
1995: Tausch B; Härter M; Niebling W; Dieter G; Berger M
[Implementation and evaluation of quality circles in general practice]
Zeitschrift für ärztliche Fortbildung 1995;89(4):402-5.
1995: Riemann D; Vollmann J; Hohagen F; Lohner H; König A; Faller C; Edali N; Berger M
[Treatment of depression with sleep deprivation and sleep phase advancement]
Fortschritte der Neurologie-Psychiatrie 1995;63(7):270-6.
1995: Mühlhauser I; Bott U; Overmann H; Wagener W; Bender R; Jörgens V; Berger M
Liberalized diet in patients with type 1 diabetes.
Journal of internal medicine 1995;237(6):591-7.
1995: Bauer J; Hüll M; Berger M
[Pathogenetic factors of Alzheimer disease]
Zeitschrift für Gerontologie und Geriatrie : Organ der Deutschen Gesellschaft für Gerontologie und Geriatrie 1995;28(3):155.
1995: Trabert W; Hohagen F; Winkelmann G; Berger M
A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
Pharmacopsychiatry 1995;28(3):95-7.
1995: Gann H; Riemann D; Stoll S; Berger M; Müller W E
Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
Pharmacopsychiatry 1995;28(3):80-3.
1995: Berger M; Mühlhauser I
Implementation of intensified insulin therapy: a European perspective.
Diabetic medicine : a journal of the British Diabetic Association 1995;12(3):201-8.
1995: Frommberger U; Angenendt J; Berger M
[Treatment of panic disorders and agoraphobia. Psychotherapy, psychopharmacotherapy and their combination]
Der Nervenarzt 1995;66(3):173-86.
1995: Walden J; von Wegerer J; Roed I; Berger M
Effects of the serotonin-1A agonists buspirone and ipsapirone on field potentials in the hippocampus slice: comparison with carbamzepine and verapamil.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1995;5(1):57-61.
1995: Kimmerle R; Zass R P; Cupisti S; Somville T; Bender R; Pawlowski B; Berger M
Pregnancies in women with diabetic nephropathy: long-term outcome for mother and child.
Diabetologia 1995;38(2):227-35.
1995: Schramm E; Hohagen F; Käppler C; Grasshoff U; Berger M
Mental comorbidity of chronic insomnia in general practice attenders using DSM-III-R.
Acta psychiatrica Scandinavica 1995;91(1):10-7.
1995: Walden J; Fritze J; Van Calker D; Berger M; Grunze H
A calcium antagonist for the treatment of depressive episodes: single case reports.
Journal of psychiatric research 1995;29(1):71-6.
1995: Voderholzer U; Wirz-Justice A; Demisch L; Berger M; Riemann D
[Case report: treatment of a patient with sleep phase advance disorder with phototherapy]
Wiener medizinische Wochenschrift (1946) 1995;145(17-18):470-2.
1995: Berger M; Hohagen F; König A; Vollmann J; Lohner H; Faller C; Edali N; Riemann D
[Chronotherapeutic approaches in depressive disorders]
Wiener medizinische Wochenschrift (1946) 1995;145(17-18):418-22.
1995: Huell M; Strauss S; Volk B; Berger M; Bauer J
Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients.
Acta neuropathologica 1995;89(6):544-51.
1994: Kimmerle R; Schmitt G; Berger M
[Contraception in patients with type I diabetes: a survey of 808 women of reproductive age]
Geburtshilfe und Frauenheilkunde 1994;54(12):691-6.
1994: Riemann D; Schnitzler M; Hohagen F; Berger M
[Depression and sleep--the status of current research]
Fortschritte der Neurologie-Psychiatrie 1994;62(12):458-78.
1994: Hohagen F; Käppler C; Schramm E; Riemann D; Weyerer S; Berger M
Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders.
Sleep 1994;17(6):551-4.
1994: Hohagen F; Käppler C; Schramm E; Rink K; Weyerer S; Riemann D; Berger M
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities.
Acta psychiatrica Scandinavica 1994;90(2):102-8.
1994: Hohagen F; Lis S; Riemann D; Krieger S; Meyer C; Montero R F; Grunze H; Berger M
Influence of biperiden and bornaprine on sleep in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;11(1):29-32.
1994: Ampudia-Blasco F J; Heinemann L; Bender R; Schmidt A; Heise T; Berger M; Starke A A
Comparative dose-related time-action profiles of glibenclamide and a new non-sulphonylurea drug, AG-EE 623 ZW, during euglycaemic clamp in healthy subjects.
Diabetologia 1994;37(7):703-7.
1994: Gann H; Riemann D; Hohagen F; Müller W E; Berger M
The influence of carbamazepine on sleep-EEG and the clonidine test in healthy subjects: results of a preliminary study.
Biological psychiatry 1994;35(11):893-6.
1994: Bott U; Jörgens V; Grüsser M; Bender R; Mühlhauser I; Berger M
Predictors of glycaemic control in type 1 diabetic patients after participation in an intensified treatment and teaching programme.
Diabetic medicine : a journal of the British Diabetic Association 1994;11(4):362-71.
1994: Riemann D; Hohagen F; Krieger S; Gann H; Müller W E; Olbrich R; Wark H J; Bohus M; Löw H; Berger M
Cholinergic REM induction test: muscarinic supersensitivity underlies polysomnographic findings in both depression and schizophrenia.
Journal of psychiatric research 1994;28(3):195-210.
1994: Gebicke-Haerter P J; Appel K; Honegger P; Berger M
Changes of beta-amyloid precursor protein splice patterns in brain cell aggregate cultures.
Journal of neuroscience research 1994;38(1):32-40.
1994: Sindelka G; Heinemann L; Berger M; Frenck W; Chantelau E
Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects.
Diabetologia 1994;37(4):377-80.
1994: Gebicke-Haerter P J; Appel K; Taylor G D; Schobert A; Rich I N; Northoff H; Berger M
Rat microglial interleukin-3.
Journal of neuroimmunology 1994;50(2):203-14.
1994: Bauer J; Hohagen F; Ebert T; Timmer J; Ganter U; Krieger S; Lis S; Postler E; Voderholzer U; Berger M
Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle.
The Clinical investigator 1994;72(4):315.
1994: Starostina E G; Antsiferov M; Galstyan G R; Trautner C; Jörgens V; Bott U; Mühlhauser I; Berger M; Dedov I I
Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow--blood glucose versus urine glucose self-monitoring.
Diabetologia 1994;37(2):170-6.
1994: Sawicki P T; Didjurgeit U; Mühlhauser I; Bender R; Heinemann L; Berger M
Smoking is associated with progression of diabetic nephropathy.
Diabetes care 1994;17(2):126-31.
1994: Kimmerle R; Wimmer T; Markus M; Heinemann L; Vester E; Berger M
[Risk factors in hyperlipidemic patients with coronary heart disease one year after PTCA]
Zeitschrift für Kardiologie 1994;83(1):9-15.
1994: Riemann D; Hohagen F; Bahro M; Berger M
Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.
European archives of psychiatry and clinical neuroscience 1994;243(5):279-90.
1994: Hohagen F; Lis S; Krieger S; Winkelmann G; Riemann D; Fritsch-Montero R; Rey E; Aldenhoff J; Berger M
Sleep EEG of patients with obsessive-compulsive disorder.
European archives of psychiatry and clinical neuroscience 1994;243(5):273-8.
1994: Förstner U; Bohus M; Gebicke-Härter P J; Baumer B; Berger M; van Calker D
Decreased agonist-stimulated Ca2+ response in neutrophils from patients under chronic lithium therapy.
European archives of psychiatry and clinical neuroscience 1994;243(5):240-3.
1994: Hohagen F; Montero R F; Weiss E; Lis S; Schönbrunn E; Dressing H; Riemann D; Berger M
Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics?
European archives of psychiatry and clinical neuroscience 1994;244(2):65-72.
1994: Riemann D; Hohagen F; Bahro M; Lis S; Stadmüller G; Gann H; Berger M
Cholinergic neurotransmission, REM sleep and depression.
Journal of psychosomatic research 1994;38 Suppl 1():15-25.
1993: Sawicki P T; Mühlhauser I; Didjurgeit U; Berger M
Improvement of hypertension care by a structured treatment and teaching programme.
Journal of human hypertension 1993;7(6):571-3.
1993: Hohagen F; Riemann D; Spiegel R; Holzhauer M; Berger M
Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1993;9(3):225-32.
1993: Riemann D; Wiegand M; Lauer C J; Berger M
Naps after total sleep deprivation in depressed patients: are they depressiogenic?
Psychiatry research 1993;49(2):109-20.
1993: Trautner C; Richter B; Berger M
Cost-effectiveness of a structured treatment and teaching programme on asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1993;6(10):1485-91.
1993: Sawicki P T; Didjurgeit U; Mühlhauser I; Berger M
Behaviour therapy versus doctor's anti-smoking advice in diabetic patients.
Journal of internal medicine 1993;234(4):407-9.
1993: Bahro M; Riemann D; Stadtmüller G; Berger M; Gattaz W F
REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age depression.
Biological psychiatry 1993;34(7):482-6.
1993: Kimmerle R; Weiss R; Berger M; Kurz K H
Effectiveness, safety, and acceptability of a copper intrauterine device (CU Safe 300) in type I diabetic women.
Diabetes care 1993;16(9):1227-30.
1993: Müller H U; Riemann D; Berger M; Müller W E
The influence of total sleep deprivation on urinary excretion of catecholamine metabolites in major depression.
Acta psychiatrica Scandinavica 1993;88(1):16-20.
1993: Berger M
[Cholesterol non-consensus in primary prevention of coronary heart disease. Methodologic problems in the interpretation of epidemiologic studies]
Zeitschrift für Kardiologie 1993;82(7):399-405.
1993: Schramm E; Hohagen F; Grasshoff U; Riemann D; Hajak G; Weess H G; Berger M
Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R.
The American journal of psychiatry 1993;150(6):867-72.
1993: Bauer J; Ganter U; Abel J; Strauss S; Jonas U; Weiss R; Gebicke-Haerter P; Volk B; Berger M
Effects of interleukin-1 and interleukin-6 on metallothionein and amyloid precursor protein expression in human neuroblastoma cells. Evidence that interleukin-6 possibly acts via a receptor different from the 80-kDa interleukin-6 receptor.
Journal of neuroimmunology 1993;45(1-2):163-73.
1993: Gann H; Riemann D; Hohagen F; Strauss L G; Dressing H; Müller W E; Berger M
48-hour rapid cycling: results of psychopathometric, polysomnographic, PET imaging and neuro-endocrine longitudinal investigations in a single case.
Journal of affective disorders 1993;28(2):133-40.
1993: Mühlhauser I; Berger M
Diabetes education and insulin therapy: when will they ever learn?
Journal of internal medicine 1993;233(4):321-6.
1993: Wiegand M; Riemann D; Schreiber W; Lauer C J; Berger M
Effect of morning and afternoon naps on mood after total sleep deprivation in patients with major depression.
Biological psychiatry 1993;33(6):467-76.
1993: Jörgens V; Grüsser M; Bott U; Mühlhauser I; Berger M
Effective and safe translation of intensified insulin therapy to general internal medicine departments.
Diabetologia 1993;36(2):99-105.
1993: Mühlhauser I; Sawicki P T; Didjurgeit U; Jörgens V; Trampisch H J; Berger M
Evaluation of a structured treatment and teaching programme on hypertension in general practice.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1993;15(1):125-42.
1993: Vollmann J; Berger M
Sleep deprivation with consecutive sleep-phase advance therapy in patients with major depression: a pilot study.
Biological psychiatry 1993;33(1):54-7.
1993: Schubert T; Stoll L; Fleckenstein P; Riemann D; Berger M; Müller W E
Effects of single and repeated clonidine administration on the properties of central and peripheral alpha 2-adrenoceptors in man.
Pharmacology 1993;46(2):82-90.
1993: Hohagen F; Rink K; Käppler C; Schramm E; Riemann D; Weyerer S; Berger M
Prevalence and treatment of insomnia in general practice. A longitudinal study.
European archives of psychiatry and clinical neuroscience 1993;242(6):329-36.
1993: Hohagen F; Timmer J; Weyerbrock A; Fritsch-Montero R; Ganter U; Krieger S; Berger M; Bauer J
Cytokine production during sleep and wakefulness and its relationship to cortisol in healthy humans.
Neuropsychobiology 1993;28(1-2):9-16.
1993: van Calker D; Förstner U; Bohus M; Gebicke-Härter P; Hecht H; Wark H J; Berger M
Increased sensitivity to agonist stimulation of the Ca2+ response in neutrophils of manic-depressive patients: effect of lithium therapy.
Neuropsychobiology 1993;27(3):180-3.
1993: Riemann D; Gann H; Hohagen F; Bahro M; Müller W E; Berger M
The effect of carbamazepine on endocrine and sleep EEG variables in a patient with 48-hour rapid cycling, and healthy controls.
Neuropsychobiology 1993;27(3):163-70.
1992: Berger M
Risk of obesity in type II diabetes mellitus.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1992;16 Suppl 4():S29-33.
1992: Walden J; Grunze H; Olbrich H; Berger M
[Importance of calcium ions and calcium antagonists in affective psychoses]
Fortschritte der Neurologie-Psychiatrie 1992;60(12):471-6.
1992: Gann H; Riemann D; Hohagen F; Dressing H; Müller W E; Berger M
The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulation.
Journal of affective disorders 1992;26(3):179-89.
1992: Starke A A; Frilling A; Becker H; Röher H D; Berger M
Are CAT-scans necessary for preoperative localization of insulinomas?
The European journal of medicine 1992;1(7):411-3.
1992: Sawicki P T; Baba T; Berger M; Starke A
Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance.
Journal of the American Society of Nephrology : JASN 1992;3(4 Suppl):S64-8.
1992: Dressing H; Riemann D; Gann H; Berger M
The effects of biperiden on nap sleep after sleep deprivation in depressed patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1992;7(1):1-5.
1992: Kimmerle R; Heinemann L; Delecki A; Berger M
Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women.
Diabetes care 1992;15(8):1034-7.
1992: Sawicki P T; Heinemann L; Starke A; Berger M
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.
Diabetologia 1992;35(7):649-52.
1992: Riemann D; Berger M
Sleep, age, depression and the cholinergic REM induction test with RS 86.
Progress in neuro-psychopharmacology & biological psychiatry 1992;16(3):311-6.
1992: Mühlhauser I; Sulzer M; Berger M
Quality assessment of diabetes care according to the recommendations of the St. Vincent Declaration: a population-based study in a rural area of Austria.
Diabetologia 1992;35(5):429-35.
1992: Riemann D; Hohagen F; Fritsch-Montero R; Krieger S; Gann H; Dressing H; Muller W; Berger M
Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
Acta psychiatrica Belgica 1992;92(3):151-71.
1992: Heinemann L; Starke A A; Hohmann A; Berger M
Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal.
Hormone and metabolic research. Supplement series 1992;26():137-9.
1991: Riemann D; Hohagen F; Fleckenstein P; Schredl M; Berger M
The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
Psychiatry research 1991;38(3):247-60.
1991: Mühlhauser I; Heinemann L; Karinganamattom J; Schuwirth W; Berger M
Accuracy of blood glucose self monitoring in elderly insulin treated diabetic patients.
Diabète & métabolisme 1991;17(5):476-82.
1991: Mühlhauser I; Heinemann L; Fritsche E; von Lennep K; Berger M
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations.
Diabetes care 1991;14(8):745-9.
1991: Mühlhauser I; Richter B; Kraut D; Weske G; Worth H; Berger M
Evaluation of a structured treatment and teaching programme on asthma.
Journal of internal medicine 1991;230(2):157-64.
1991: Riemann D; Gann H; Fleckenstein P; Hohagen F; Olbrich R; Berger M
Effect of RS 86 on REM latency in schizophrenia.
Psychiatry research 1991;38(1):89-92.
1991: Sawicki P T; Kaiser S; Heinemann L; Frenzel H; Berger M
Prevalence of renal artery stenosis in diabetes mellitus--an autopsy study.
Journal of internal medicine 1991;229(6):489-92.
1991: Lauer C J; Riemann D; Wiegand M; Berger M
From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers.
Biological psychiatry 1991;29(10):979-93.
1991: Wiegand M; Schreiber W; Lauer C; Berger M
The action of clenbuterol on sleep and symptomatology in depressives.
Pharmacopsychiatry 1991;24(3):89-92.
1991: Mühlhauser I; Toth G; Sawicki P T; Berger M
Severe hypoglycemia in type I diabetic patients with impaired kidney function.
Diabetes care 1991;14(4):344-6.
1991: Riemann D; Wiegand M; Berger M
Are there predictors for sleep deprivation response in depressed patients?
Biological psychiatry 1991;29(7):707-10.
1991: Sawicki P T; Karschny L; Stolpe V; Wolf E; Berger M
Color discrimination and accuracy of blood glucose self-monitoring in type I diabetic patients.
Diabetes care 1991;14(2):135-7.
1991: Dippel B; Kemper J; Berger M
Folie à six: a case report on induced psychotic disorder.
Acta psychiatrica Scandinavica 1991;83(2):137-41.
1991: Dressing H; Berger M
[Post-traumatic stress disorders. On the development of the current disease concept]
Der Nervenarzt 1991;62(1):16-26.
1991: Berger M; Riemann D; Krieg C
Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
Acta psychiatrica Scandinavica. Supplementum 1991;366():52-60.
1990: Riemann D; Velthaus S; Laubenthal S; Müller W E; Berger M
REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials.
Pharmacopsychiatry 1990;23(6):253-8.
1990: Sonnenberg G E; Kemmer F W; Berger M
Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia.
Diabetologia 1990;33(11):696-703.
1990: Sawicki P T; Didjurgeit U; Mühlhauser I; Heinemann L; Berger M
Near-normotension and near-normoglycemia in blind type I diabetic patients with overt diabetic nephropathy.
The Journal of diabetic complications 1990;4(4):179-83.
1990: Riemann D; Löw H; Schredl M; Wiegand M; Dippel B; Berger M
Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.
Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Université d'Ottawa 1990;15(2):93-9.
1990: Heinemann L; Starke A A; Heding L; Jensen I; Berger M
Action profiles of fast onset insulin analogues.
Diabetologia 1990;33(6):384-6.
1990: Schönbrunn E; Riemann D; Hohagen F; Berger M
[Restless legs and sleep apnea syndrome--random coincidence or causal relation?]
Der Nervenarzt 1990;61(5):306-11.
1990: Lauer C J; Krieg J C; Riemann D; Zulley J; Berger M
A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa.
Journal of affective disorders 1990;18(4):235-45.
1990: Sawicki P T; Mühlhauser I; Baba T; Berger M
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?
Diabetologia 1990;33(2):121-4.
1990: Riemann D; Berger M
The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder.
Acta psychiatrica Scandinavica 1990;81(1):24-31.
1989: Heinemann L; Sonnenberg G E; Hohmann A; Ritzenhoff A; Berger M; Benn J; Sönksen P; Kelley D; Gerich J; Aoki T
Pulsatile insulin infusion and glucose-homeostasis in well-controlled type 1 (insulin-dependent) diabetic patients.
Journal of internal medicine 1989;226(5):325-30.
1989: Spraul M; Streeck A; Nieradzik M; Berger M
Uniform elimination pattern for glibenclamide in healthy Caucasian males.
Arzneimittel-Forschung 1989;39(11):1449-50.
1989: Lauer C; Krieg J C; Zulley J; Riemann D; Berger M
[Sleep in anorexia nervosa, bulimia nervosa and depressive diseases: a polysomnographic comparative study]
Fortschritte der Neurologie-Psychiatrie 1989;57(10):403-10.
1989: Mauricio-Leguizamo G; Heinemann L; Scharf R E; Berger M
Effect of 8 hours of hyperinsulinaemia on haemostatic parameters in healthy man.
Diabetologia 1989;32(8):606-10.
1989: Sawicki P T; Heinemann L; Berger M
Comparison of methods for determination of microalbuminuria in diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(5):412-5.
1989: Chantelau E; Spraul M; Mühlhauser I; Gause R; Berger M
Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.
Diabetologia 1989;32(7):421-6.
1989: Riemann D; Berger M
EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(2):145-52.
1989: Berger M; Riemann D; Höchli D; Spiegel R
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
Archives of general psychiatry 1989;46(5):421-8.
1989: Starke A A; Heinemann L; Hohmann A; Berger M
[Action profile of human ultralente insulin compared with human NPH-insulin]
Deutsche medizinische Wochenschrift (1946) 1989;114(16):618-22.
1989: Starke A A; Heinemann L; Hohmann A; Berger M
The action profiles of human NPH insulin preparations.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(3):239-44.
1989: Chantelau E; Zwecker M; Weiss H; Kluxen G; Berger M
Fundus polaroid screening for diabetic retinopathy. Is one print per patient enough?
Diabetes care 1989;12(3):223-6.
1989: Lauer C; Schreiber W; Berger M; Pirke K M; Holsboer F; Krieg J C
The effect of neuroendocrine secretion on brain morphology and EEG sleep in patients with eating disorders.
European archives of psychiatry and neurological sciences 1989;238(4):208-12.
1989: Wiegand M; Berger M
Action of trimipramine on sleep and pituitary hormone secretion.
Drugs 1989;38 Suppl 1():35-42; discussion 49-50.
1988: Kronsbein P; Jörgens V; Mühlhauser I; Scholz V; Venhaus A; Berger M
Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes.
Lancet 1988;2(8625):1407-11.
1988: Lauer C; Zulley J; Krieg J C; Riemann D; Berger M
EEG sleep and the cholinergic REM induction test in anorexic and bulimic patients.
Psychiatry research 1988;26(2):171-81.
1988: Spraul M; Chantelau E; Koumoulidou J; Berger M
Subcutaneous or nonsubcutaneous injection of insulin.
Diabetes care 1988;11(9):733-6.
1988: Sawicki P T; Heinemann L; Rave K; Hohmann A; Berger M
Atrial natriuretic factor in various stages of diabetic nephropathy.
The Journal of diabetic complications 1988;2(4):207-9.
1988: Mühlhauser I; Sawicki P; Didjurgeit U; Jörgens V; Berger M
Uncontrolled hypertension in type 1 diabetes: assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(7):693-8.
1988: Spraul M; Chantelau E; Schönbach A M; Berger M
Glycemic effects of beer in IDDM patients. Studies with constant insulin delivery.
Diabetes care 1988;11(8):659-61.
1988: Dippel B; Riemann D; Majer-Trendel K; Berger M
[Manifest dream content of anorexia and bulimia patients--an intermediate report]
Psychotherapie, Psychosomatik, medizinische Psychologie 1988;38(6):199-204.
1988: Chantelau E; Weiss H; Weber U; Sonnenberg G E; Berger M
Four-year follow-up of retinal status and glycosylated haemoglobin in patients with insulin-dependent diabetes mellitus.
Diabète & métabolisme 1988;14(3):259-63.
1988: Riemann D; Joy D; Höchli D; Lauer C; Zulley J; Berger M
Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
Psychiatry research 1988;24(2):137-47.
1988: Kelley D; Mitrakou A; Marsh H; Schwenk F; Benn J; Sonnenberg G; Arcangeli M; Aoki T; Sorensen J; Berger M
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.
The Journal of clinical investigation 1988;81(5):1563-71.
1988: Bossert S; Schnabel E; Krieg J C; Berger M
Modifications and problems of behavioural inpatient management of anorexia nervosa: a "patient-suited" approach?
Acta psychiatrica Scandinavica 1988;77(1):105-10.
1988: Bossert S; Berger M; Krieg J C; Schreiber W; Junker M; von Zerssen D
Cortisol response to various stressful situations: relationship to personality variables and coping styles.
Neuropsychobiology 1988;20(1):36-42.
1988: Pycior M; Kemmer F W; Berger M
Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man.
Hormone and metabolic research. Supplement series 1988;18():22-4.
1988: Berger M; Krieg C; Bossert S; Schreiber W; von Zerssen D
Past and present strategies of research on the HPA-axis in psychiatry.
Acta psychiatrica Scandinavica. Supplementum 1988;341():112-25.
1988: Sawicki P; Heinemann L; Rave K; Berger M
[Atrial natriuretic factor in patients with type 1 diabetes mellitus in various stages of diabetic nephropathy]
Zeitschrift für Kardiologie 1988;77 Suppl 2():111-3.
1988: Schreiber W; Krieg J C; Bossert S; Junker M; Rauschhuber R; Stalla G K; Müller O A; Berger M
Methodological aspects of hCRF-stimulated ACTH and cortisol secretion in healthy subjects.
Psychoneuroendocrinology 1988;13(6):487-95.
1987: Berger M; Bossert S; Krieg J C; Dirlich G; Ettmeier W; Schreiber W; von Zerssen D
Interindividual differences in the susceptibility of the cortisol system: an important factor for the degree of hypercortisolism in stress situations?
Biological psychiatry 1987;22(11):1327-39.
1987: Krieg J C; Berger M
REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives.
Acta psychiatrica Scandinavica 1987;76(5):600-2.
1987: Berger M
Human insulin: much ado about hypoglycaemia (un)awareness.
Diabetologia 1987;30(11):829-33.
1987: Kemmer F W; Tacken M; Berger M
Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment.
Diabetes 1987;36(10):1178-82.
1987: Bossert S; Schnabel E; Krieg J C; Molitor P; Kemper J; Berger M
[Concept of integrative inpatient-ambulatory therapy in patients with anorexia nervosa: a revised therapeutic approach]
Psychotherapie, Psychosomatik, medizinische Psychologie 1987;37(9-10):331-6.
1987: Mühlhauser I; Bruckner I; Berger M; Cheta D; Jörgens V; Ionescu-Tîrgoviste C; Scholz V; Mincu I
Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study.
Diabetologia 1987;30(9):681-90.
1987: Krieg J C; Bossert S; Pirke K M; von Zerssen D; Berger M
The influence of the muscarinic agonist RS 86 on the cortisol system.
Biological psychiatry 1987;22(5):573-82.
1987: Wiegand M; Berger M; Zulley J; Lauer C; von Zerssen D
The influence of daytime naps on the therapeutic effect of sleep deprivation.
Biological psychiatry 1987;22(3):389-92.
1987: von Zerssen D; Berger M; Doerr P
Neuroendocrinological studies on depression with special reference to research at the Max-Planck-Institute of Psychiatry.
Pharmacopsychiatry 1987;20(1):8-22.
1987: Dippel B; Lauer C; Riemann D; Majer-Trendel K; Krieg J C; Berger M
Sleep and dreams in eating disorders.
Psychotherapy and psychosomatics 1987;48(1-4):165-9.
1986: Höchli D; Riemann D; Zulley J; Berger M
Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder.
Biological psychiatry 1986;21(12):1217-20.
1986: Höchli D; Riemann D; Zulley J; Berger M
Is there a relationship between response to total sleep deprivation and efficacy of clomipramine treatment in depressed patients?
Acta psychiatrica Scandinavica 1986;74(2):190-2.
1986: Mühlhauser I; Klemm A B; Boor B; Scholz V; Berger M
[Length of stay and length of work incapacity in patients with Type I diabetes. Effects of a diabetes treatment and education program]
Deutsche medizinische Wochenschrift (1946) 1986;111(22):854-7.
1985: Berger M; Höchli D; Zulley J; Lauer C; von Zerssen D
Cholinomimetic drug RS 86, REM sleep, and depression.
Lancet 1985;1(8442):1385-6.
1985: Mühlhauser I; Berger M; Sonnenberg G; Koch J; Jörgens V; Schernthaner G; Scholz V; Pädagogin D
Incidence and management of severe hypoglycemia in 434 adults with insulin-dependent diabetes mellitus.
Diabetes care 1985;8(3):268-73.
1985: Berger M; Pirke K M; Krieg C J; von Zerssen D; Muller O A; Stalla G K
ACTH and cortisol levels in healthy probands and psychiatric patients following the dexamethasone suppression test.
The American journal of psychiatry 1985;142(2):268-9.
1984: Berger M; Doerr P; von Zerssen D
Physostigmine's influence on DST results.
The American journal of psychiatry 1984;141(3):469-70.
1984: Scholz V; Jorgens V; Berger M; Konsbein P; Muhlhauser I; Hornke L; Willms B
Evaluation of a postgraduate course for diabetes educators.
The Diabetes educator 1984;10 SPEC NO():80-4.
1983: Mühlhauser I; Jörgens V; Berger M; Graninger W; Gürtler W; Hornke L; Kunz A; Schernthaner G; Scholz V; Voss H E
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.
Diabetologia 1983;25(6):470-6.
1983: Berger M; Lund R; Bronisch T; von Zerssen D
REM latency in neurotic and endogenous depression and the cholinergic REM induction test.
Psychiatry research 1983;10(2):113-23.
1983: Berger M; Bordi C; Cüppers H J; Berchtold P; Gries F A; Münterfering H; Sailer R; Zimmermann H; Orci L
Functional and morphologic characterization of human insulinomas.
Diabetes 1983;32(10):921-31.
1983: Berger M; Pirke K M; Doerr P; Krieg C; von Zersseen D
Influence of weight loss on the dexamethasone suppression test.
Archives of general psychiatry 1983;40(5):585-6.
1983: Kemmer F W; Sonnenberg G E; Cüppers H J; Berger M
[Absorption kinetics of semisynthetic human insulin and biosynthetic human insulin]
MMW, Münchener medizinische Wochenschrift 1983;Suppl 1():S85-90.
1983: Sonnenberg G E; Kemmer F W; Cüppers H J; Berger M
Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
Diabetes care 1983;6 Suppl 1():35-9.
1982: Kemmer F W; Sonnenberg G; Cüppers H J; Berger M
Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
Diabetes care 1982;5 Suppl 2():23-8.
1982: Berger M; Doerr P; Lund R; Bronisch T; von Zerssen D
Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?
Biological psychiatry 1982;17(11):1217-42.
1982: Berger M; Cüppers H J; Hegner H; Jörgens V; Berchtold P
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
Diabetes care 1982;5(2):77-91.
1982: Cüppers H J; Erdmann D; Schubert H; Berchtold P; Berger M
Glucose tolerance, serum insulin, and serum lipids in athletes.
Current problems in clinical biochemistry 1982;11():155-65.
1981: Berchtold P; Cüppers H J; Berger M
[Diuretics, serum glucose and diabetes mellitus]
Deutsche medizinische Wochenschrift (1946) 1981;106(50):1712-4.
1980: Leidinger F; Jörgens V; Chantelau E; Berchtold P; Berger M
[Blood-sugar self control. A means for the diabetic of controlling his metabolic management. Quality control of a battery-run pocket size reflectometer (glucose-meter)]
Fortschritte der Medizin 1980;98(28):1041-4.
1980: Berger M; Jörgens V; Cüppers H J; Kemmer F W; Berchtold P
[Effects on glycoregulation of muscular activity as a function of its intensity and duration]
Journées annuelles de diabétologie de l'Hôtel-Dieu 1980;():117-29.

Sign-in to see more